Sun Pharmaceuticals Industries is in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The Company’s products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are situated in India, the United States and Brazil, among others.They also produce intermediates in a range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.
SHORT TERM PERSPECTIVE
| Company | Sun Pharmaceutical Industries Ltd. |
| Recommendation | Accumulate (Rs.520-RS.525) |
| CMP | Rs 531.70 |
| Stop Loss (SL) | Rs 500 |
| Target Price | Rs.560-Rs.590 |
| Time Horizon | 2-4 Weeks |
Intermediate and short term trend is up in this stock. After a period of trading sideways; The stock has given a breakout from a rectangle pattern which is bullish in nature. Increase in volume and positive diversion from oscillator indicate that stock can move higher from current levels so one can accumulate the stock between 520-525 With a stop loss of Rs. 500 on closing basis and for the target Price of Rs 560-590. Time frame should be 2-4 week.
DISCLOSURE IN PURSUANCE OF SECTION 19 OF SEBI (RA) REGULATION 2014
Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as read more
For Daily Share Market Updates, Daily debt market review, Market Research Analysis reports, Weekly Techno-Funda Report, Fundamental Analysis Report, Monthly Recommended stock Picks, Equity Trading Tips, Upcoming IPO/NFO/Bonds/Ncd’s updates & other related information Subscribe our research plan